Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

In Vitro Percutaneous Absorption of Ondansetron Hydrochloride from Pressure-sensitive Adhesive Matrices through Hairless Mouse Skin

  • Gwak, Hye-Sun (College of Pharmacy, Chosun University) ;
  • Oh, Ik-Sang (College of Pharmacy, Dongduk Women s University) ;
  • Chun, In-Koo (College of Pharmacy, Dongduk Women s University)
  • Published : 2003.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

To investigate the feasibility of developing a new ondansetron transdermal system, the effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) from a pressure-sensitive adhesive (PSA) matrices across dorsal hairless mouse skin were studied. Vehicles employed in this study consisted of various ratios of propylene glycol monocaprylate (PGMC)-diethylene glycol monoethyl ether (DGME) co-solvents and PGMC-propylene glycol (PG) co-solvents with 3% oleic acid. $Duro-Tak^\circledR$ 87-2100 and $Duro-Tak^\circledR$ 87-2196 were used as PSAs. The concentration of DGME in PGMC-DGME co-solvent system affected the release rate; as the concentration of DGME increased, the release rate decreased. The cumulative release amount of OS increased as the ratio of PSA to drug solution decreased. The permeation flux was also primarily affected by the amount of PSAs; as the amount decreased, the permeation flux increased. The overall fluxes from matrix formulations were significantly lower when compared to those obtained from solution formulations. The ratio of PG to PGMC did not affect permeation flux, while the lag time decreased significantly from $5.14\pm3.31 to 0.31\pm0.12$ h as the PG increased from 40% to 60%.

Keywords

References

  1. Aungst, B. J., Blake, J. A., and Hussain, M. A., Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res., 7, 712-718 (1990) https://doi.org/10.1023/A:1015859320604
  2. Barry, B. W., Mode of action of penetration enhancers in human skin. J. Contr. Res., 6, 85-97 (1987) https://doi.org/10.1016/0168-3659(87)90066-6
  3. Blackwell, C. P. and Harding, S. M., The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol., 25 (Suppl 1), S21-S24 (1989)
  4. Butcher, M. E., Global experience with ondansetron and future potential. Oncology, 50, 191-197 (1993) https://doi.org/10.1159/000227176
  5. Chien, Y. W. and Lambert, H. J., Controlled drug release from polymeric delivery devices II: differentiation between partition-controlled and matrix-controlled drug release mechanism. J. Pharm. Sci., 63, 515-519 (1974) https://doi.org/10.1002/jps.2600630405
  6. Cho, Y. J. and Choi, H. K., Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm.,169, 95-104 (1998) https://doi.org/10.1016/S0378-5173(98)00115-X
  7. Green, P. G., Guy, R. H., and Hadgraft, J., In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int. J. Pharm., 48, 103-111 (1988) https://doi.org/10.1016/0378-5173(88)90252-9
  8. Gwak, H. S. and Chun, I. K., Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm., 236, 57-64 (2002) https://doi.org/10.1016/S0378-5173(02)00009-1
  9. Gwak, H. S., Kim, S. U., and Chun, I. K., Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch. Pharm. Res., 25, 392-396 (2002) https://doi.org/10.1007/BF02976645
  10. Gwak, H. S., Oh, I. S., and Chun, I. K., Transdermal delivery of ondansetron hydrochloride: effect of vehicles and penetration enhancers. Drug Dev. Ind. Pharm., accepted (2003a)
  11. Gwak, H. S., Oh, I. S., and Chun, I. K., Solubility and physicochemical stability of ondansetron hydrochloride in various vehicles. J. Kor. Pharm. Sci., 33, 45-49 (2003b)
  12. Hesketh, P. J. and Gandara, D. R., Serotonin antagonists: a new class of antiemetic agents. J. Natl. Cancer Inst., 83, 613-620 (1991) https://doi.org/10.1093/jnci/83.9.613
  13. McKenzie, R., Kovac, A., O'Connor, T., Duncalf, D., Angel, J., Gratz, I., Tolpin, E., McLeskey, C., and Joslyn, A., Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology, 78, 21-28 (1993) https://doi.org/10.1097/00000542-199301000-00005
  14. M${\phi}$llgard, B. and Hoelgaard, A., Vehicle effect in topical drug delivery I. Influence of glycols and drug concentration on skin transport. Acta. Pharm. Suec., 20, 433-442 (1983)
  15. Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., and Barzegar-Jalali, M., The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm., 250, 359-369 (2003) https://doi.org/10.1016/S0378-5173(02)00554-9
  16. Roy, S. D., Gutierrez, M, Flynn, G. L., and Cleary, G. W., Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci., 85, 491-495 (1996) https://doi.org/10.1021/js950415w
  17. Santoyo, S., Arellano, A., Ygartua, P., and Martin, C., Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm., 117, 219-224 (1995) https://doi.org/10.1016/0378-5173(94)00344-5
  18. Scuderi, P., Wetchler, B., Sung, Y. F., Mingus, M., DuPen, S., Claybon, L., Leslie, J., Talke, P., Apfelbaum, J., and Sharifi-Azad, S., Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology, 78, 15-20 (1993) https://doi.org/10.1097/00000542-199301000-00004
  19. Yamada, M., Uda, Y., and Tanigawara, Y., Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull., 35, 3399-3406 (1987) https://doi.org/10.1248/cpb.35.3399